PEPTIDREAM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,468 JPY | -3.29% |
|
-3.89% | -1.21% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Calendar
2024-05-13
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,468
JPY
Average target price
2,667
JPY
Spread / Average Target
+81.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.21% | 1.27B | |
| -3.14% | 102B | |
| +1.73% | 96.07B | |
| -1.80% | 21.66B | |
| -17.47% | 20.77B | |
| -6.91% | 18.53B | |
| -42.00% | 16.91B | |
| -28.10% | 13.79B | |
| -0.11% | 13.33B | |
| +20.66% | 10.94B |
- Stock Market
- Equities
- 4587 Stock
- News PeptiDream Inc.
- Peptidream : and Four Others Establish Joint Venture to Develop COVID-19 Treating Therapeutics
